JP2006507839A5 - - Google Patents

Download PDF

Info

Publication number
JP2006507839A5
JP2006507839A5 JP2004557456A JP2004557456A JP2006507839A5 JP 2006507839 A5 JP2006507839 A5 JP 2006507839A5 JP 2004557456 A JP2004557456 A JP 2004557456A JP 2004557456 A JP2004557456 A JP 2004557456A JP 2006507839 A5 JP2006507839 A5 JP 2006507839A5
Authority
JP
Japan
Prior art keywords
antibody
hinge region
composition
exogenous
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004557456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006507839A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038198 external-priority patent/WO2004050847A2/en
Publication of JP2006507839A publication Critical patent/JP2006507839A/ja
Publication of JP2006507839A5 publication Critical patent/JP2006507839A5/ja
Abandoned legal-status Critical Current

Links

JP2004557456A 2002-11-27 2003-11-26 乳中に安定して産生される改変抗体およびその製造方法 Abandoned JP2006507839A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42960602P 2002-11-27 2002-11-27
PCT/US2003/038198 WO2004050847A2 (en) 2002-11-27 2003-11-26 Modified antibodies stably produced in milk and methods of producing same

Publications (2)

Publication Number Publication Date
JP2006507839A JP2006507839A (ja) 2006-03-09
JP2006507839A5 true JP2006507839A5 (https=) 2007-04-05

Family

ID=32469344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004557456A Abandoned JP2006507839A (ja) 2002-11-27 2003-11-26 乳中に安定して産生される改変抗体およびその製造方法

Country Status (8)

Country Link
US (1) US20050097625A1 (https=)
EP (1) EP1565564A4 (https=)
JP (1) JP2006507839A (https=)
CN (1) CN1729298A (https=)
AU (1) AU2003298787A1 (https=)
BR (1) BR0316643A (https=)
CA (1) CA2506629A1 (https=)
WO (1) WO2004050847A2 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000007I2 (de) 1986-04-09 2010-12-30 Genzyme Corp Genetisch transformierte Tiere, die ein gewünschtes Protein in Milch absondern
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
NZ544924A (en) * 2003-06-27 2009-03-31 Biogen Idec Inc Modified binding molecules comprising connecting peptides
WO2006074399A2 (en) * 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
US20080019905A9 (en) * 2005-02-18 2008-01-24 Strome Scott E Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
KR20140133958A (ko) * 2005-10-21 2014-11-20 엘에프비 유에스에이, 인크. 항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및 사용 방법
AU2012201010B2 (en) * 2005-10-21 2015-01-22 Genzyme Corporation Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
ES2548714T3 (es) * 2006-09-01 2015-10-20 Zymogenetics, Inc. Anticuerpos monoclonales IL-31 y procedimientos de uso
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
AU2008311367B2 (en) 2007-10-05 2014-11-13 Ac Immune S.A. Use of anti-amyloid beta antibody in ocular diseases
EP2279003A4 (en) * 2008-05-01 2013-04-03 Gtc Biotherapeutics Inc ANTI-CD137 ANTIBODY AS A MEANS FOR THE TREATMENT OF INFLAMMATORY DISEASES
EP2598882B1 (en) 2010-07-30 2017-07-26 AC Immune S.A. Safe and functional humanized antibodies for use in treating an amyloidosis
ES2811526T3 (es) 2010-12-30 2021-03-12 Lab Francais Du Fractionnement Glicoles como agentes de inactivación de patógenos
CN104168913A (zh) * 2011-08-10 2014-11-26 法国化学与生物科技实验室 高半乳糖基化抗体
US10034921B2 (en) 2013-02-13 2018-07-31 Laboratoire Français Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
EP3594230A1 (en) * 2013-02-13 2020-01-15 Laboratoire Français du Fractionnement et des Biotechnologies Highly galactosylated anti-tnf-alpha antibodies and uses thereof
CN105358577A (zh) * 2013-02-13 2016-02-24 法国化学与生物科技实验室 具有经修饰的糖基化的西妥昔单抗及其用途
EP3016729B1 (fr) 2013-07-05 2020-03-25 Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme Matrice de chromatographie d'affinité
FR3025515B1 (fr) 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
FR3034420A1 (fr) 2015-03-31 2016-10-07 Lab Francais Du Fractionnement Anticorps monoclonaux anti-cd303
FR3034419B1 (fr) 2015-04-02 2017-12-15 Lab Francais Du Fractionnement Procede de purification d'une proteine recombinante therapeutique a partir d'un lait transgenique
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
WO2017194593A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
US10513537B2 (en) 2016-05-11 2019-12-24 Ge Healthcare Bioprocess R&D Ab Separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
FR3060394B1 (fr) 2016-12-16 2019-05-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Combinaison d'anticorps anti-cd303 et anti-amhrii
FR3060395B1 (fr) 2016-12-16 2019-05-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Combinaison d'anticorps anti-cd303 et anti-her2
FR3076294B1 (fr) 2017-12-29 2022-01-28 Lab Francais Du Fractionnement Procede de purification d'anticorps a partir de lait brut
CA3223956A1 (en) 2021-12-20 2023-06-29 Vetoquinol Sa Anti-canine interleukine-31-receptor a (il-31ra) antibodies and the uses thereof
EP4662240A2 (fr) 2023-02-09 2025-12-17 Commissariat à l'Energie Atomique et aux Energies Alternatives Fragment fab mutant pour l'obtention de conjugués mono- ou bi-fonctionnalisés site-spécifiques
WO2025114614A1 (en) 2023-11-30 2025-06-05 Vetoquinol Sa Anti-canine interleukine-4-receptor alpha (il-4rα) antibodies and the uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US4897465A (en) * 1988-10-12 1990-01-30 Abbott Laboratories Enrichment and concentration of proteins by ultrafiltration
US5827690A (en) * 1993-12-20 1998-10-27 Genzyme Transgenics Corporatiion Transgenic production of antibodies in milk
AU692841B2 (en) * 1994-03-09 1998-06-18 Abbott Laboratories Transgenic animals producing oligosaccharides and glycoconjugates
AU707440B2 (en) * 1994-03-29 1999-07-08 Celltech Therapeutics Limited Antibodies against E-selectin
RU2189251C2 (ru) * 1994-12-23 2002-09-20 Зенека Лимитед Химические соединения
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk

Similar Documents

Publication Publication Date Title
JP2006507839A5 (https=)
JP6473423B2 (ja) 修飾された免疫グロブリン重鎖配列を有する非ヒト動物
KR102276752B1 (ko) 단일 도메인 결합 단백질을 생산하는 비-인간 동물
LTC3284753I2 (https=)
WO2003040169A3 (en) Human monoclonal antibodies to dendritic cells
NO20040752L (no) Humane antistoffer spesifikke for interleukin 15 (IL-15)
WO2004076620A3 (en) Human antibodies specific for interleukin 15 (il-15)
DK1210374T3 (da) Humane, monoklonale antistoffer over for prostataspecifikt membranantigen
ATE527278T1 (de) Humane monoklonale antikörper gegen interleukin 8 (il-8)
WO2003064606A3 (en) Human monoclonal antibodies to prostate specific membrane antigen (psma)
JP2009525758A5 (https=)
ATE553131T1 (de) Humane monoklonale antikörper gegen dendritische zellen
WO2004056847A3 (en) Human monoclonal antibodies to epidermal growth factor receptor (egfr)
CN109906030A (zh) 用于产生仅重链抗体的经基因修饰的非人动物和方法
PL392809A1 (pl) Przeciwciało monoklonalne przeciwko CD40 i jego część wiążąca antygen, zawierająca go kompozycja i jego zastosowanie, oraz linia komórkowa, cząsteczka kwasu nukleinowego, wektor komórka gospodarza i sposób wytwarzania
RU2017106292A (ru) Мыши, у которых вырабатываются связывающие белки, содержащие vl-домены
JP2010527622A5 (https=)
DE102009047243A1 (de) Monospezifische Polypeptidreagenzien
WO2008048871A3 (en) Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses
TH79238A (th) แอนติบอดีของมนุษย์ที่จำเพาะสำหรับอินเตอร์ลิวคิน 15 (il-15)